Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014)
Bio-Rad Laboratories (BIO) reported Curent Deferred Tax Liability of $13.8 million for Q2 2014, up 45.49% quarter-over-quarter from $9.5 million in Q4 2013.
Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014) Analysis & Trends
Bio-Rad Laboratories (BIO) has 2 years of Curent Deferred Tax Liability data on file, last reported at $13.8 million in Q2 2014.
- Curent Deferred Tax Liability for Q2 2014 came in at $13.8 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2014 was $13.8 million (changed N/A YoY), and the FY2013 annual result was $9.5 million, changed N/A from the prior year.
- Curent Deferred Tax Liability improved to $13.8 million in Q2 2014 per BIO's latest filing, from $9.5 million in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $13.8 million in Q2 2014 and troughed at $9.5 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | 7.62 Bn | 6.05 Bn | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 13.76 Mn |
| Jun 30, 2014 | 13.76 Mn |
| Dec 31, 2013 | 9.45 Mn |
| Dec 31, 2013 | 9.45 Mn |